<!DOCTYPE html>
<html lang="en">
<head>
    <!-- Google Tag Manager -->
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
    new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
    j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
    'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
    })(window,document,'script','dataLayer','GTM-WSLDZ2QB');</script>
    <!-- End Google Tag Manager -->

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

    <!-- *** CORE SEO & Page Info *** -->
    <title>OpenAI &amp; FDA Discuss AI in Drug Evaluation to Speed Approvals - Dacoola</title>
    <meta name="description" content="OpenAI and the FDA are exploring AI in drug evaluation to accelerate approvals. Learn how AI could transform regulatory processes.">
    <meta name="author" content="AI News Team">
    <meta name="keywords" content="AI in drug evaluation, FDA and OpenAI collaboration, cderGPT, AI in healthcare, drug approval modernization, AI for precision medicine, regulatory AI challenges, ChatGPT Gov, AI in clinical trials, FDA AI officer">

    <!-- *** CANONICAL URL *** -->
    <link rel="canonical" href="https://dacoolaa.netlify.app/articles/openai-and-fda-collaborate-on-ai-in-drug-evaluation-to-modernize-approvals.html">

    <!-- *** OPEN GRAPH *** -->
    <meta property="og:title" content="OpenAI &amp; FDA Discuss AI in Drug Evaluation to Speed Approvals">
    <meta property="og:description" content="OpenAI and the FDA are exploring AI in drug evaluation to accelerate approvals. Learn how AI could transform regulatory processes.">
    <meta property="og:image" content="https://media.wired.com/photos/681ba1b6c38af307cb440ad9/191:100/w_1280,c_limit/openai-fda-biz-2210029399.jpg">
    <meta property="og:url" content="https://dacoolaa.netlify.app/articles/openai-and-fda-collaborate-on-ai-in-drug-evaluation-to-modernize-approvals.html">
    <meta property="og:type" content="article">
    <meta property="og:site_name" content="Dacoola">
    
    <meta property="article:published_time" content="2025-05-07T19:59:59Z">
    <meta property="article:modified_time" content="2025-05-07T19:59:59Z">
    
    
    <meta property="article:tag" content="AI in drug evaluation">
    
    <meta property="article:tag" content="FDA and OpenAI collaboration">
    
    <meta property="article:tag" content="cderGPT">
    
    <meta property="article:tag" content="AI in healthcare">
    
    <meta property="article:tag" content="drug approval modernization">
    
    <meta property="article:tag" content="AI for precision medicine">
    
    <meta property="article:tag" content="regulatory AI challenges">
    
    <meta property="article:tag" content="ChatGPT Gov">
    
    <meta property="article:tag" content="AI in clinical trials">
    
    <meta property="article:tag" content="FDA AI officer">
    

    <!-- *** TWITTER CARD *** -->
    <meta name="twitter:card" content="summary_large_image">
    <meta name="twitter:title" content="OpenAI &amp; FDA Discuss AI in Drug Evaluation to Speed Approvals">
    <meta name="twitter:description" content="OpenAI and the FDA are exploring AI in drug evaluation to accelerate approvals. Learn how AI could transform regulatory processes.">
    <meta name="twitter:image" content="https://media.wired.com/photos/681ba1b6c38af307cb440ad9/191:100/w_1280,c_limit/openai-fda-biz-2210029399.jpg">

    <!-- *** Stylesheets & Icons *** -->
    <link rel="stylesheet" href="../css/styles.css">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.2/css/all.min.css" integrity="sha512-SnH5WK+bZxgPHs44uWIX+LLJAJ9/2PkPKZ5QiAj6Ta86w+fsb2TkcmfRyVX3pBnMFcV7oQPJkl9QevSCWr3W6A==" crossorigin="anonymous" referrerpolicy="no-referrer" />
    <link rel="icon" type="image/png" href="https://i.ibb.co/W7xMqdT/dacoola-image-logo.png">

    <!-- *** JSON-LD Structured Data *** -->
    <script type="application/ld+json">
    {
      "@context": "https://schema.org",
      "@type": "NewsArticle",
      "headline": "OpenAI &amp; FDA Discuss AI in Drug Evaluation to Speed Approvals",
      "description": "OpenAI and the FDA are exploring AI in drug evaluation to accelerate approvals. Learn how AI could transform regulatory processes.",
      "keywords": ["AI in drug evaluation", "FDA and OpenAI collaboration", "cderGPT", "AI in healthcare", "drug approval modernization", "AI for precision medicine", "regulatory AI challenges", "ChatGPT Gov", "AI in clinical trials", "FDA AI officer"],
      "mainEntityOfPage": { "@type": "WebPage", "@id": "https://dacoolaa.netlify.app/articles/openai-and-fda-collaborate-on-ai-in-drug-evaluation-to-modernize-approvals.html" },
      "image": [
        {
          "@type": "ImageObject",
          "url": "https://media.wired.com/photos/681ba1b6c38af307cb440ad9/191:100/w_1280,c_limit/openai-fda-biz-2210029399.jpg"
        }
      ],
      "datePublished": "2025-05-07T19:59:59Z",
      "dateModified": "2025-05-07T19:59:59Z",
      "author": { "@type": "Person", "name": "AI News Team" },
      "publisher": {
        "@type": "Organization",
        "name": "Dacoola",
        "logo": { "@type": "ImageObject", "url": "https://dacoolaa.netlify.app" }
      }
    }
    </script>

    <!-- Google Analytics (gtag.js) -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-WGJ5MFBC6X"></script>
    <script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());
      gtag('config', 'G-WGJ5MFBC6X');
    </script>

</head>
<body>
    <!-- Google Tag Manager (noscript) -->
    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WSLDZ2QB"
    height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    <!-- End Google Tag Manager (noscript) -->

    <header id="navbar-placeholder">
        <!-- Navbar loaded by JS -->
    </header>

    <div class="site-content-wrapper">
        <div class="main-content-grid">

            <aside class="sidebar related-news">
                <h2>Related News</h2>
                <div id="related-news-content">
                    <!-- JS will populate this list -->
                </div>
            </aside>

            <article class="main-article"
                data-article-id="3e9c58f9d636060cb1f5c36efc4266b7b7200796db328d311a573442ff1e8476"
                data-article-topic="Health"
                data-article-tags='["AI in drug evaluation", "FDA and OpenAI collaboration", "cderGPT", "AI in healthcare", "drug approval modernization", "AI for precision medicine", "regulatory AI challenges", "ChatGPT Gov", "AI in clinical trials", "FDA AI officer"]'
                data-audio-url="">

                <header>
                    <h1 id="article-headline">OpenAI and FDA Collaborate on AI in Drug Evaluation to Modernize Approvals</h1>
                    <div class="article-meta-container">
                        <div class="article-meta">
                            Published on <span id="publish-date">May 07, 2025</span>
                            by <span id="author-name">AI News Team</span>
                        </div>
                    </div>
                </header>

                <figure class="article-image-container">
                    <img id="article-image" src="https://media.wired.com/photos/681ba1b6c38af307cb440ad9/191:100/w_1280,c_limit/openai-fda-biz-2210029399.jpg" alt="OpenAI &amp; FDA Discuss AI in Drug Evaluation to Speed Approvals">
                </figure>

                <section id="article-body">
                    <h2>OpenAI and FDA Collaborate on AI in Drug Evaluation to Modernize Approvals</h2>
<p>The FDA is in talks with OpenAI to explore how artificial intelligence (AI) can streamline the drug evaluation process, potentially reducing the time it takes for new treatments to reach patients. Sources reveal that discussions involve a project called <strong>cderGPT</strong>, likely referencing the FDA’s Center for Drug Evaluation and Research (CDER). FDA Commissioner Marty Makary has emphasized the need to modernize regulatory processes with AI, citing its potential to assist in scientific reviews for diabetes and cancer treatments. While no formal agreement has been reached, these talks signal a growing push to integrate AI into drug approval workflows.  </p>
<h3>How AI Could Revolutionize Drug Evaluation</h3>
<p>The FDA’s interest in <strong>AI in drug evaluation</strong> aligns with broader efforts to shorten review times, which currently average about a year. AI could automate administrative tasks—such as checking application completeness—while more advanced applications might assist in data analysis and risk assessment. Jeremy Walsh, the FDA’s first AI officer, is leading discussions with OpenAI and other stakeholders, including HHS’s acting chief AI officer, Peter Bowman-Davis.  </p>
<p>Former FDA Commissioner Robert Califf notes that AI has been used internally for years, but its role in final approvals remains limited. Rafael Rosengarten of Genialis advocates for AI adoption but stresses the need for clear guidelines on model training and performance standards to ensure reliability.  </p>
<h4>Potential Benefits and Risks</h4>
<div class="pros-cons-container">  
  <div class="pros-section">  
    <h5 class="section-title">Pros</h5>  
    <div class="item-list">  
      - **Faster Approvals:** AI could reduce bottlenecks in reviewing drug applications.  
      - **Precision Medicine:** LLMs might enhance personalized treatment evaluations.  
    </div>  
  </div>  
  <div class="cons-section">  
    <h5 class="section-title">Cons</h5>  
    <div class="item-list">  
      - **Hallucination Risks:** AI-generated inaccuracies could compromise safety.  
      - **Regulatory Gaps:** Lack of clear policies for AI-assisted decisions.  
    </div>  
  </div>  
</div>

<h4>Challenges and Ethical Considerations</h4>
<p>Critics highlight concerns about AI’s reliability, particularly its tendency to "hallucinate" plausible but false information. An ex-FDA employee warns that unchecked AI integration could introduce errors into critical reviews. Meanwhile, OpenAI is developing <strong>ChatGPT Gov</strong>, a government-compliant version of its model, aiming for FedRAMP certification to handle sensitive data.  </p>
<h4>What’s Next?</h4>
<p>The FDA is already researching AI applications, including a fellowship for LLM development in drug regulation. If successful, AI could eventually expand beyond administrative tasks to assist in clinical trial analysis and post-market surveillance. However, as PhRMA’s Andrew Powaleny notes, patient safety must remain the priority in any AI adoption.  </p>
<h4>Frequently Asked Questions</h4>
<div class="faq-section">  
  <details class="faq-item">  
    <summary class="faq-question">What is cderGPT?</summary>  
    <div class="faq-answer-content">  
      <p>A potential AI tool being discussed between OpenAI and the FDA, likely tied to the Center for Drug Evaluation and Research (CDER).</p>  
    </div>  
  </details>  
  <details class="faq-item">  
    <summary class="faq-question">How could AI speed up drug approvals?</summary>  
    <div class="faq-answer-content">  
      <p>By automating routine checks, analyzing large datasets, and flagging inconsistencies in applications.</p>  
    </div>  
  </details>  
</div>
                    
                </section>

                <footer>
                    
                    <div class="tags">
                        Tags: <span id="article-tags"><a href="https://dacoolaa.netlify.app/topic.html?name=AI%20in%20drug%20evaluation" class="tag-link">AI in drug evaluation</a>, <a href="https://dacoolaa.netlify.app/topic.html?name=FDA%20and%20OpenAI%20collaboration" class="tag-link">FDA and OpenAI collaboration</a>, <a href="https://dacoolaa.netlify.app/topic.html?name=cderGPT" class="tag-link">cderGPT</a>, <a href="https://dacoolaa.netlify.app/topic.html?name=AI%20in%20healthcare" class="tag-link">AI in healthcare</a>, <a href="https://dacoolaa.netlify.app/topic.html?name=drug%20approval%20modernization" class="tag-link">drug approval modernization</a>, <a href="https://dacoolaa.netlify.app/topic.html?name=AI%20for%20precision%20medicine" class="tag-link">AI for precision medicine</a>, <a href="https://dacoolaa.netlify.app/topic.html?name=regulatory%20AI%20challenges" class="tag-link">regulatory AI challenges</a>, <a href="https://dacoolaa.netlify.app/topic.html?name=ChatGPT%20Gov" class="tag-link">ChatGPT Gov</a>, <a href="https://dacoolaa.netlify.app/topic.html?name=AI%20in%20clinical%20trials" class="tag-link">AI in clinical trials</a>, <a href="https://dacoolaa.netlify.app/topic.html?name=FDA%20AI%20officer" class="tag-link">FDA AI officer</a></span>
                    </div>
                </footer>

            </article>

            <aside class="sidebar latest-news">
                <h2>Latest News</h2>
                <div id="latest-news-content">
                    <!-- JS will populate this list -->
                </div>
            </aside>

        </div> <!-- End main-content-grid -->
    </div> <!-- End site-content-wrapper -->

    <!-- GLOBAL FIXED BROWSER TTS PLAYER BUTTON -->
    <button id="global-tts-player-button" title="Listen to article (Browser TTS)" aria-label="Listen to main article content">
        <i class="fas fa-headphones" aria-hidden="true"></i>
    </button>
    

    <script src="../js/script.js"></script>

</body>
</html>